Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |